MarketPeel
Insider Trading Intelligence
Pricing
…
PL

Patrick Lin

PCSA
CHIEF BUSINESS - STRATEGY OFF · PROCESSA PHARMACEUTICALS, INC. · CIK 0001799363
FILING MIX · LIFETIME85%/15%
BUYS
52
SELLS
9
TOTAL VALUE
$379.6K
COMPANIES
1
ACTIVE SINCE
Oct 2020
HOLDINGS NOW
13,113
AVG SELL PX
$1.57
TRADE KIND
SHOWING 61 / 61
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
13 backtested trades · 8 horizons · 12 pending
Forward-return performance of every backtestable P/S trade by Patrick Lin, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d13+69.23%+7.78%+0.77%+7.00%+7.06%—
14d13+69.23%+8.28%+1.95%+6.33%+2.42%—
30d13+69.23%+5.08%+0.81%+5.12%-0.97%—
60d13+30.77%-4.24%-0.16%-4.54%-8.50%—
90d13(2 pending)+18.18%-7.02%-1.45%-5.57%-7.72%—
180d13(3 pending)+10.00%-27.96%-2.37%-25.59%-25.47%—
1y13(3 pending)+0.00%-68.18%+1.83%-70.01%-73.36%—
2y13(4 pending)+0.00%-92.38%+19.88%-112.25%-115.25%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
PCSA · 13,113 shares · as of Jun 30, 2026
0353,021706,0411,059,0621,412,082202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 52 buys / 9 sellsCOVERAGE · 23 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASE
Chief Business - Strategy Off
2,106$1.93$4.1K13,113Jun 30, 2026Jul 1, 2026 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASE
Chief Business - Strategy Off
1,831$2.22$4.1K11,007Jun 15, 2026Jun 16, 2026 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASE
Chief Business - Strategy Off
1,582$2.57$4.1K9,176May 29, 2026Jun 1, 2026 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASE
Chief Business - Strategy Off
1,369$2.97$4.1K7,594May 15, 2026May 19, 2026 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASE
Chief Business - Strategy Off
1,511$2.69$4.1K6,236Apr 30, 2026May 1, 2026 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASE
Chief Business - Strategy Off
1,369$2.97$4.1K4,725Apr 15, 2026Apr 17, 2026 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASE
Chief Business - Strategy Off
1,603$2.54$4.1K3,356Mar 31, 2026Apr 1, 2026 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
SALE
Chief Business - Strategy Off
193——0Jan 1, 2026Feb 4, 2026 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASE
Chief Business - Strategy Off
193——1,753Jan 1, 2026Feb 4, 2026 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
68,000——68,000Oct 1, 2025Oct 3, 2025 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
204,000——204,000Oct 1, 2025Oct 3, 2025 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
1,401,650——1,412,082Jul 24, 2025Jul 28, 2025 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
SALE
Chief Business - Strategy Off
4,814$0.41$2.0K38,727Apr 1, 2025Apr 11, 2025 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASE
Chief Business - Strategy Off
14,482——43,541Apr 1, 2025Apr 11, 2025 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
43,500——43,500Jan 29, 2025Feb 18, 2025 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
21,750——21,750Jan 29, 2025Feb 18, 2025 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASE
Chief Business - Strategy Off
43,500$0.80$34.7K43,500Jan 27, 2025Jan 29, 2025 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
SALE
Chief Business - Strategy Off
271$1.71$46329,059Jul 10, 2024Aug 2, 2024 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASE
Chief Business - Strategy Off
644——29,330Jul 10, 2024Aug 2, 2024 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
339——24,575Jun 28, 2024Aug 2, 2024 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
339——24,914Jun 28, 2024Aug 2, 2024 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
2,713——22,201Jun 28, 2024Aug 2, 2024 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
2,035——24,236Jun 28, 2024Aug 2, 2024 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASE
Chief Business - Strategy Off
1,675——29,225Apr 5, 2024Aug 2, 2024 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
SALE
Chief Business - Strategy Off
539$2.79$1.5K28,686Apr 5, 2024Aug 2, 2024 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASE
Chief Business - Strategy Off
1,500$2.40$3.6K27,478Feb 1, 2024Feb 1, 2024 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASE
Chief Business - Strategy Off
2,500$2.37$5.9K25,978Jan 31, 2024Feb 1, 2024 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
SALE
Chief Business - Strategy Off
539$2.79$1.5K28,614Jan 1, 2024Apr 12, 2024 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
SALE
Chief Business - Strategy Off
1,675——20,132Jan 1, 2024Apr 12, 2024 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASE
Chief Business - Strategy Off
1,675——29,153Jan 1, 2024Apr 12, 2024 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
5,000$0.32$1.6K469,535Oct 12, 2023Oct 12, 2023 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
13,700$0.21$2.9K464,535Oct 10, 2023Oct 10, 2023 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
12,500$0.80$10.0K450,835Feb 9, 2023Feb 10, 2023 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
55,107——399,638Jan 1, 2023Jan 4, 2023 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
40,690——440,328Jan 1, 2023Jan 4, 2023 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
10,851——344,531Dec 31, 2022Jan 4, 2023 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
10,850——333,680Sep 30, 2022Oct 3, 2022 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASE
Chief Business - Strategy Off
7,601——440,991Aug 5, 2022Aug 9, 2022 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
SALE
Chief Business - Strategy Off
2,656$3.17$8.4K438,335Aug 5, 2022Aug 9, 2022 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
20,064——322,830Jun 30, 2022Jul 5, 2022 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASE
Chief Business - Strategy Off
2,000$1.59$3.2K433,390May 17, 2022May 19, 2022 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASE
Chief Business - Strategy Off
800$3.54$2.8K431,390Apr 7, 2022Apr 8, 2022 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASE
Chief Business - Strategy Off
1,200$3.13$3.8K430,590Apr 6, 2022Apr 8, 2022 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
247,841——302,766Apr 1, 2022Apr 11, 2022 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
10,715——37,781Mar 31, 2022Apr 4, 2022 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
6,722——22,780Dec 31, 2021Jan 6, 2022 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASE
Chief Business - Strategy Off
3,000$4.00$12.0K429,390Dec 14, 2021Dec 16, 2021 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASE
Chief Business - Strategy Off
3,000$4.00$12.0K429,390Dec 14, 2021Dec 16, 2021 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASE
Chief Business - Strategy Off
3,500$4.80$16.8K426,390Dec 3, 2021Dec 7, 2021 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
4,286——27,066Nov 1, 2021Apr 4, 2022 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
SALEGRANT
Stock grant
6,024——16,058Sep 30, 2021Jan 6, 2022 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
SALEGRANT
Stock grant
6,024——6,024Sep 30, 2021Oct 4, 2021 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASE
Chief Business - Strategy Off
4,000$6.02$24.1K422,890Aug 26, 2021Aug 30, 2021 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
7,601——418,890Aug 5, 2021Aug 9, 2021 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
12,858——12,858Jul 8, 2021Jul 9, 2021 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
1,907——10,034Jul 8, 2021Jul 9, 2021 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
8,572——8,572Jul 8, 2021Jul 9, 2021 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASE
Chief Business - Strategy Off
2,000$6.65$13.3K401,737Jun 21, 2021Jun 22, 2021 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
8,127——8,127Jun 8, 2021Jun 10, 2021 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASE
Chief Business - Strategy Off
31,250$2.10$65.6K399,737Oct 1, 2020Oct 5, 2020 ↗View →
PCSA
PROCESSA PHARMACEUTICALS, INC.
PURCHASE
Chief Business - Strategy Off
31,250$4.00$125.0K399,737Oct 1, 2020Oct 5, 2020 ↗View →
Other insiders · PCSA
Loading peer insiders…
About this filer
CIK 0001799363
ROLE
Chief Business - Strategy Off
PRIMARY
PCSA
COMPANIES
1
ACTIVE SINCE
Oct 2020
MARKETPEEL · /INSIDER/0001799363DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback